Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sartorius Stedim Biotech
  6. News
  7. Summary
    DIM   FR0013154002

SARTORIUS STEDIM BIOTECH

(DIM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

SARTORIUS STEDIM BIOTECH : Gets a Buy rating from JP Morgan

01/29/2021 | 01:58am EST

In a research note, JP Morgan analyst Richard Vosser has maintained his recommendation on the stock with a Buy rating. The target price is increased from EUR 350 to EUR 400.


© MarketScreener with dpa-AFX Analyser 2021
All news about SARTORIUS STEDIM BIOTECH
01:33aJiangsu Nhwa Pharma Signs Nearly $18 Million Deal to License Lundbeck's Schizophrenia D..
MT
11/26Sartorius to Invest EUR100 Million in France by 2025, Create Up to 400 Jobs
DJ
11/26SARTORIUS STEDIM BIOTECH : grows operations in France and is investing 100 million...
PU
11/25Sartorius to Invest Around EUR270 Million in South Korea Expansion
DJ
11/25SARTORIUS STEDIM BIOTECH : significantly expands activities in South Korea
PU
10/21CHA BIOTECH : Unit Signs Contract with Sartorius for Viral Vectors Process Technology
MT
10/20GLOBAL MARKETS LIVE : Kering, Netflix, Roche, United Airlines, Xiaomi...
10/20SARTORIUS STEDIM BIOTECH : Q3 Profit Soars On Significant Demand Momentum
MT
10/20SARTORIUS' : Nine-Month Profit Soars Almost 93% On Strong Revenue Growth
MT
10/20SARTORIUS STEDIM BIOTECH : Earnings Release 9M|2021
PU
More news
Analyst Recommendations on SARTORIUS STEDIM BIOTECH
More recommendations
Financials
Sales 2021 2 868 M 3 242 M 3 242 M
Net income 2021 594 M 671 M 671 M
Net Debt 2021 557 M 629 M 629 M
P/E ratio 2021 80,6x
Yield 2021 0,27%
Capitalization 47 307 M 53 316 M 53 475 M
EV / Sales 2021 16,7x
EV / Sales 2022 14,6x
Nbr of Employees 9 619
Free-Float 26,2%
Chart SARTORIUS STEDIM BIOTECH
Duration : Period :
Sartorius Stedim Biotech Technical Analysis Chart | DIM | FR0013154002 | MarketScreener
Technical analysis trends SARTORIUS STEDIM BIOTECH
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 513,20 €
Average target price 463,33 €
Spread / Average Target -9,72%
EPS Revisions
Managers and Directors
Joachim Kreuzburg Chairman & Chief Executive Officer
Oscar-Werner Reif Executive VP-Research & Development
Volker Niebel Executive VP-Operations & Information Technology
Henri Riey Independent Non-Executive Director
Anne-Marie Graffin Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
SARTORIUS STEDIM BIOTECH76.24%53 762
ABBOTT LABORATORIES14.97%222 592
MEDTRONIC PLC-5.20%149 347
BECTON, DICKINSON AND COMPANY-2.05%69 611
HOYA CORPORATION25.86%59 428
DEXCOM, INC.60.11%57 374